Cooper Companies Stock falls after a revenue miss, weaker Q4 guidance and channel inventory pressure trigger analyst target cuts.
Cooper Companies cut Q4 EPS to $1.05-$1.09 from $1.19 following Q3 revenue miss ($1.066B vs $1.098B estimate); U.S. inventory destocking blamed. The guidance cut signals margin pressure in healthcare distribution and caution on consumer spending; relevant for SaaS vendors and sector investors.
The Cooper Companies, Inc. (NASDAQ:COO) shares traded lower Thursday after investors reacted to fiscal third-quarter results and weaker near-term guidance.
The decline far outpaced broader weakness, with the S&P 500 down 0.4% and the Health Care sector falling 0.51%.
Cooper shares had already dropped 15.96% after hours Wednesday to $53.35.
• Cooper Companies stock is at significant support. Why are COO shares at support?
Revenue Miss and Inventory Pressure Weigh
Cooper Companies stock drops after hours on Q3 earnings, strategic review, and guidance update.
CooperCompanies beat Q3 EPS but missed sales and cut FY26 guidance; shares fell 16.8% as analysts lowered targets and downgraded…
Investors hammered Cooper Companies on Thursday after the medtech's fiscal third-quarter sales lagged expectations.
Cooper Companies will report Q3 earnings Sept. 9; analysts expect EPS of $1.12 and revenue of $1.10B.
The Cooper Companies, Inc. (COO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud…
Cooper Companies Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cooper Companies (COO)
